Teva Pharmaceuticals Agrees to Pay Rhode Island $21 Million, Provide Opioid Treatment Options
21 Mars 2022 - 8:45PM
Dow Jones News
By Denny Jacob
Teva Pharmaceuticals said Monday it will pay Rhode Island $21
million over 13 years and provide two treatment options over 10
years after it reached an agreement with the state's Attorney
General that settles the state's opioid-related claims.
Under the terms of the settlement, Teva will provide Narcan and
Suboxone. Narcan is a nasal spray that can treat narcotic overdose
in an emergency situation, while Suboxone can treat narcotic
dependence. Teva said the value of the treatments combined is $78.5
million.
Teva said the settlement agreement is not an admission of any
liability or wrongdoing. The company added that it continues to
actively negotiate a national settlement.
Representatives for Attorney General Peter Neronha didn't
immediately return Dow Jones's request for comment.
Teva Pharmaceuticals is a U.S. affiliate of Teva Pharmaceutical
Industries Ltd.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
March 21, 2022 15:30 ET (19:30 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
